Circulating angiotensin converting enzyme levels are increased in concentric, but not eccentric, left ventricular hypertrophy in elderly men

Journal of Hypertension

Volumn 15, Issue 8, 1997, Pages 885-890

  Reneland, Richard ^a   Andrén, Bertil ^a   Lind, Lars ^a   Andersson, Per Erik ^a   Hänni, Arvo ^a   Lithell, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiotensin converting enzyme; Blood pressure; Echocardiography; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; ARTICLE; BODY MASS; CASE REPORT; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ENZYME BLOOD LEVEL; FLUOROMETRY; GEOMETRY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; M MODE ECHOCARDIOGRAPHY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; THICKNESS; VASCULAR RESISTANCE;

EID: 0030879391     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715080-00013     Document Type: Article

References (29)

1. Dahlöf B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992, 5:95-110.
2. Dahlöf B, Herlitz H, Aurell M, Hansson L: Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system. Am J Hypertens 1992, 5:900-911.
3. Schiffrin EL, Deng LY, Larochelle P: Effects of a β-blocker or a converting enzyme inhibitor on resitance arteries in essential hypertension. Hypertension 1994, 23:83-91.
4. Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker. Am J Hypertens 1995, 8:229-236.
5. Thybo NK, Stephens N, Cooper A, Aalkjær C, Haegerty AM, Mulvany MJ: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995, 25:474-481.
6. Schelling P, Fischer H, Ganten D: Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991, 9:3-15.
7. Linz W, Wiemer G, Schaper J, Zimmermann R, Nagasawa K, Gohlke P, et al.: Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis. Mol Cell Biochem 1995, 147:89-97.
8. Bonithon-Kopp C, Ducimetière P, Touboul P-J, Fève J-M, Billaud E, Courbon D, et al.: Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 1994, 89:952-954.
9. Schunkert H, Hense H-W, Danser J, Muscholl M, Luchner A, Riegger G: Association between circulating components of the renin-angiotensin-system and left ventricular mass [abstract]. Circulation 1995, 92:1-709.
10. Andrén B, Lind L, Hedenstierna G, Lithell H: Left ventricular hypertrophy and a decreased E:A ratio are common echocardiographic findings even in apparently healthy 70-year-old men. Cardiol Elderly 1995, 3:367-371.
11. Friedland J, Silverstein E: A sensitive fluorometric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976, 66:416-424.
12. Teichholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976, 37:7.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1081.
14. Ganau A, Devereux RB, Roman MJ, De Simone G, Pickering TG, Saba PS, et al.: Pattern of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550-1558.
15. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel W.B. K, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987, 59:956-960.
16. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 6:E214-E223.
17. Lind L, Andersson P, Andrén B, Hänni A, Berne C, Lithell H: Left ventricular hypertrophy in hypertension - a part of the insulin resisitance metabolic syndrome? J Hypertens 1995, 13:432-438
18. Matucci-Cerinic M, Jaffa A, Kahaleh B: Angiotensin converting enzyme: an in vivo and in vitro marker of endothelial injury. J Lab Clin Med 1992, 120:428-433.
19. Robertson AL, Khairallah PA: Angiotensin II: rapid localization in nuclei of smooth an cardiac muscle. Science 1971, 172:1138-1139.
20. Khairallah PA, Robertson AL, Davila D: Effect of angiotensin II on DNA, RNA, and protein synthesis. In Hypertension. Edited by Genest J, Koiw E. New York: Springer-Verlag; 1972:212-220.
21. Baker KM, Aceto JF: Angiotensin II stimulation of protein synthesis and cell growth in chick cells. Am J Physiol 1990, 259:H610-H618.
22. Black MJ, Bertram JF, Campbell JH, Campbell GR: Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats. J Hypertens 1995, 13:683-692.
23. Susic D, Nuñes E, Frohlich ED: Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension 1996, 28:265-268.
24. Vane JR, Änggård EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 1990, 323:27-36.
25. Shimamoto H, Shimamoto Y: Lisinopril reverses left ventricular hypertrophy through improved aortic compliance. Hypertension 1996, 28:457-463.
26. Schunkert H, Jackson B, Tang SS, Schoen FJ, Smits JF, Apstein CS, et al.: Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation 1993, 87:1328-1339.
27. Nyström F, Karlberg BE, Öhman KP: Serum angiotensin converting enzyme activity correlates positively with plasma angiotensin II in a population-based study [abstract]. J Hypertens 1996, 14 (suppl 3):S137.
28. Marian AJ, Yu Q-t, Workman R, Greve G, Roberts R: Angiotensinconverting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993, 342:1085-1086.
29. Yoneya K, Okamoto H, Machida M, Onozuka H, Noguchi M, Mikami T, et al.: Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 1995, 130:1089-1093.